AcouSort Past Earnings Performance
Past criteria checks 0/6
AcouSort's earnings have been declining at an average annual rate of -13.7%, while the Biotechs industry saw earnings growing at 17.7% annually. Revenues have been growing at an average rate of 28.8% per year.
Key information
-13.7%
Earnings growth rate
-6.0%
EPS growth rate
Biotechs Industry Growth | 0.7% |
Revenue growth rate | 28.8% |
Return on equity | -70.8% |
Net Margin | -162.0% |
Next Earnings Update | 22 May 2024 |
Recent past performance updates
Recent updates
AcouSort (STO:ACOU) Is In A Good Position To Deliver On Growth Plans
Aug 15Will AcouSort (STO:ACOU) Spend Its Cash Wisely?
Nov 25We Think AcouSort (STO:ACOU) Can Afford To Drive Business Growth
Aug 09We're Hopeful That AcouSort (STO:ACOU) Will Use Its Cash Wisely
Mar 02We're Not Very Worried About AcouSort's (STO:ACOU) Cash Burn Rate
May 03We Think AcouSort (STO:ACOU) Can Afford To Drive Business Growth
Jan 18Revenue & Expenses BreakdownBeta
How AcouSort makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 11 | -17 | 25 | 0 |
30 Sep 23 | 12 | -13 | 24 | 0 |
30 Jun 23 | 11 | -13 | 23 | 0 |
31 Mar 23 | 10 | -14 | 21 | 0 |
31 Dec 22 | 9 | -14 | 20 | 0 |
30 Sep 22 | 7 | -15 | 18 | 0 |
30 Jun 22 | 6 | -14 | 17 | 0 |
31 Mar 22 | 6 | -13 | 16 | 0 |
31 Dec 21 | 6 | -12 | 15 | 0 |
30 Sep 21 | 6 | -12 | 18 | 0 |
30 Jun 21 | 6 | -11 | 14 | 0 |
31 Mar 21 | 7 | -9 | 13 | 0 |
31 Dec 20 | 7 | -8 | 13 | 0 |
30 Sep 20 | 6 | -8 | 10 | 0 |
30 Jun 20 | 6 | -7 | 12 | 0 |
31 Mar 20 | 4 | -9 | 12 | 0 |
31 Dec 19 | 3 | -10 | 12 | 0 |
30 Sep 19 | 3 | -9 | 10 | 0 |
30 Jun 19 | 2 | -10 | 10 | 0 |
31 Mar 19 | 3 | -8 | 10 | 0 |
31 Dec 18 | 1 | -9 | 9 | 0 |
30 Sep 18 | 2 | -8 | 10 | 0 |
30 Jun 18 | 2 | -7 | 9 | 0 |
31 Mar 18 | 2 | -7 | 1 | 0 |
31 Dec 17 | 2 | -6 | 8 | 0 |
30 Sep 17 | 3 | -5 | 5 | 0 |
30 Jun 17 | 3 | -3 | 3 | 0 |
31 Mar 17 | 3 | -2 | 5 | 0 |
31 Dec 16 | 3 | -1 | 0 | 0 |
30 Sep 16 | 2 | 0 | 1 | 0 |
31 Dec 15 | 2 | 0 | 0 | 0 |
31 Dec 14 | 2 | 0 | 0 | 0 |
31 Dec 13 | 1 | 0 | 0 | 0 |
Quality Earnings: ACOU is currently unprofitable.
Growing Profit Margin: ACOU is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ACOU is unprofitable, and losses have increased over the past 5 years at a rate of 13.7% per year.
Accelerating Growth: Unable to compare ACOU's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: ACOU is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-11.5%).
Return on Equity
High ROE: ACOU has a negative Return on Equity (-70.81%), as it is currently unprofitable.